共 116 条
[1]
Ackerman MJ(2011)HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 1308-1339
[2]
Priori SG(2020)Revisiting the diagnostic yield of hypertrophic cardiomyopathy genetic testing Circ Genom Precis Med 13 135-142
[3]
Willems S(2021)Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity Nat Genet 53 128-134
[4]
Butters A(2021)Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect Nat Genet 53 1387-1398
[5]
Bagnall RD(2018)Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) Circulation 138 972-977
[6]
Ingles J(2013)Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy Genet Med 15 727-737
[7]
Harper AR(2014)Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy Mayo Clin Proc 89 142-151
[8]
Goel A(2013)Detecting rare variant effects using extreme phenotype sampling in sequencing association studies Genet Epidemiol 37 924-930
[9]
Grace C(2016)Phenotypic extremes in rare variant study designs Eur J Hum Genet 24 1158-1159
[10]
Tadros R(2009)Hypertrophic cardiomyopathy centers Am J Cardiol 104 e159-e240